Patent ID: 8461176

Claim:
An aryloazol-2-yl-cyanoethylamine compound of formula (I) that is enriched in an enantiomer that is significantly more active in vitro and in vivo compared with the other enantiomer, wherein the weight:weight ratio is at least 1.5 or higher in favor of the enantiomer that is significantly more active in vitro and in vivo, or a salt thereof: P is N; Q is C—R 2 or N; V is N; W is C—R 9 ; X is C—R 10 ; Y is C—R 11 ; R 2 is hydrogen; R 9 , R 10 and R 11 are independently of one another hydrogen, halogen, C 1 -C 6 -alkyl or halo-C 1 -C 6 -alkyl; R 3 and R 4 are hydrogen; R 5 is C 1 -C 6 -alkyl; R 6 is hydrogen or C 1 -C 6 -alkyl; R 7 is unsubstituted or substituted phenyl, wherein the substituents may each be independent of one another alkylthio, haloalkylthio, alkoxy, or haloalkoxy; Z is C(O); and a is 1.